Atlas Trials

Evaluation of the Effect of Vitreous Composition Determined by Ultrasound and Optical Coherence Tomography (OCT) on Ranibizumab Therapy

Clinical trial NCT01256632 · COMPLETED

Trial details

NCT number
NCT01256632
Sponsor
Vision Research Foundation
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Choroidal Neovascularization
Start date
2007-10-01
Primary completion
2010-10-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.